Report ID:
SQMIG35I2347 |
Region:
Global |
Published Date: October, 2024
Pages:
214
|Tables:
120
|Figures:
74
Global Antifungal Drugs Market size was valued at USD 16.28 Billion in 2022 and is poised to grow from USD 16.9 Billion in 2023 to USD 22.78 Billion by 2031, growing at a CAGR of 3.8% in the forecast period (2024-2031).
The increasing prevalence of fungal infections like aspergillosis and candidiasis are some of the primary factors contributing to the growth of the market. Fungal infections consist of systemic and superficial infections like infections of the skin, eye, mouth, and vagina. Antifungal products with fungicidal activity are primarily utilized for treating a wide range of diseases like athlete’s foot, ringworm, and fungal meningitis, created by fungal agents. Furthermore, increasing incidences of hospital-acquired or nosocomial infections and infectious diseases are also propelling the growth of the market. Fungal diseases are a public health issue as they can impact any person. Moreover, there is also a serious threat of fungal infections to people with weak immune responses like patients with AIDS. One of the primary drivers contributing to the growth of the market is the increasing incidences of fungal illnesses like aspergillosis and candidiasis. Antifungal medicines with fungicidal actions are generally utilized for treating different diseases, like ringworm and fungal meningitis, resulting in the development of the market.
Global Market Size
Largest Segment
Fastest Growth
Growth Rate
CAGR
To get more reports on the above market click here to Buy The Report
The global antifungal drugs market is segmented into drug class, indication, dosage form, distribution channel, and region. Based on drug class, the market is divided into Azoles, Echinocandins, Polyenes, and Allylamines. Based on indication, the market is segmented into Dermatophytosis, Aspergillosis, Candidiasis, and Others. Based on dosage form, the market is divided into Oral Drugs, Ointments, Powders, Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retails Pharmacies, and Others. Based on Region the market is segmented as, North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Analysis by Drug Class
Based on drug class, the market is segmented into Azoles, Echinocandins, Polyenes, and Allylamines. The azoles drug class is dominating the market with the largest market share. This is because they are the most frequently utilized drug class utilized for treating systemic fungal infection. Azoles are categorized into triazoles and imidazoles. Triazoles like fluconazole, voriconazole, and itraconazole are characterized with strong wide-spectrum activity. These provide better level of safety in comparison with other therapeutic agents. These substances support fungistatic actions by preventing fungal enzymes from operating. Azoles are prescribed for treating ocular fungal infections, systemic candidiasis, blastomycosis, and candidemia. The triazoles has less negative impact and severe drug interaction, which enhances pharmokinetic properties. These advantages are contributing to the growing dominance of azoles among the drug class in the antifungal drugs market.
The echinocandins drugs in the drug class segment is witnessing the fastest market growth in the antifungal drugs market. This drug spreads their fungicidal activity by preventing cell wall synthesis of fungi. These are efficient against viruses like yeast, molds, and fungal spores. The most frequently utilized echinocandins are cospofungin, anidulafungin, and micafungin. These are generally utilized in the treatment for invasive aspergillosis, invasive candidiasis, candidemia, and oesophageal candidiasis. In comparison with other fungistatic agents, these solutions have minimized adverse impact in accordance with drugs interaction and show wide range of activity. These factors are increasing the demand for echinocandins drugs in the drug class segment, fueling the growth of antifungal drugs market.
Analysis by Distribution Channels
Based on distribution channels, hospital pharmacies are dominating the market with maximum market share. This is because hospital pharmacies play a vital part in ensuring immediate access to vital medicines. They can serve both outpatient and in-patient services, allowing streamlined treatment of fungal infections. The demand for this segment is rapidly increasing because of their close proximity to hospitals, guaranteeing easy access to medicines, and offering emergency medication services. This segment is also growing rapidly owing to factors like cost-efficiency and following clinical guidelines. The increase of prescription rates, particularly with the introduction of fluconazole, rising the consumption of antifungal agents globally, is contributing to the growth of the segment. The use of triazoles and terbinafine are also extending because of the evolving prescribing patterns and resistance epidemiology transformations. These factors are increasing the growth of hospital pharmacies segment.
The retail pharmacy segment is witnessing the fastest growth in the antifungal drugs market. This is mainly because pharmacies are forming chains and following the trend of mergers, leading to the growth of the segment. Such mergers improve market consolidation, improving the physical presence and skills of pharmacists. This segment is also increasing competitive edge due to the rise of online pharmacies. These pharmacies offer immediate access, proximity, quality, and security assurance. With the increase in fungal infections, the requirement for early detection and treatment boosts self-medication. This is particularly true with the over-the counter antifungal medications accessible in retail pharmacies. This trend of self-medication is immensely contributing to the growth of retail pharmacy in antifungal drugs market.
To get detailed analysis on other segments, Request For Free Sample Report
Based on region, North America is dominating the antifungal drugs market with maximum market share. The growth of the market in the region is mainly attributed to the immensely developed medical infrastructure, better affordability, and rising awareness. The market leaders are constantly trying to more market share with various strategic initiatives. Many companies are also trying to increase their commercialization abilities to enhance profit margins. Furthermore, the increased approvals for various formulations and constant research and development by manufacturers are also massively driving the antifungal drugs market in the region of North America. The increased prevalence of clinical urgency for utilizing these antifungal medications more frequently is also contributing to growth of the market. These factors are positively influencing the market in North America.
The region of Asia Pacific is witnessing the fastest growth in the antifungal drugs market. This growth can be attributed to the increasing base of possible customers, growing disposable income, rising availability of drugs, and vital unmet clinical necessities, resulting in the growth of the global market. Many companies in the market are also focusing on investing in R&D and selling brand specific medications at a reasonable rate in the region, increasing the demand for the market. Many governments in countries like Japan are also encouraging people to use antifungal drugs by taking many initiatives like increasing insurance coverage. This is also significantly boosting the growth of the market in Asia Pacific.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
The rising prevalence of fungal and nosocomial infections are the primary driver of the advancement of the antifungal drugs market. Antifungal agents are efficient against systemic and superficial infections. These infections are attained from exposure to contaminated surfaces in hospitals or humid conditions. The antifungal drugs market is experiencing significant growth due to the rising awareness about fungal diseases among people and medical providers is contributing to this demand.
Improved medical infrastructure frequently results to enhanced diagnostic facilities. Better-quality diagnostic abilities are leading to more accurate and timely detection of fungal infections This is enabling patients and medical providers to take prompt and targeted treatment with antifungal drugs. Accessibility of advanced medical facilities are encouraging people to try medical attention for fungal infections, increasing the overall patient pool for antifungal drugs.
Restraints
In most cases fungal infections go undiagnosed because of lack of awareness among medical providers and the general public. This can lead to delayed or insufficient treatment. This restraint highlights the significance of educational initiatives as it can increase awareness and enhance diagnostic practices. Furthermore, the lack of understanding between patients and medical providers can also lead to under diagnosis and undertreatment.
Adverse side effects related to antifungal medications present another huge difficulty. Patients can experience substantial side effects, which can result in minimizing the efficiency of the treatment and poor adherence. Furthermore, the high effect of the antifungal drugs like nephrotoxicity, hypokalemia, bone marrow suppression is also negatively influencing the growth of the market.
Request Free Customization of this report to help us to meet your business objectives.
The antifungal drugs market is extremely concentrated. The market is highly competitive due to the presence of many medium and small-sized organizations. These companies provide a wide range of generic and OTC drugs to fufill customer needs. To gain a competitive edge and increase their market shares, companies are emphasizing on strategies like product differentiation and distribution agreements. They are also engaging in partnerships and collaborations with end-users. Companies are also following tactics like aggressive pricing, online marketing, and strategic acquisitions for geographical and portfolio expansion.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global antifungal drugs market is constantly growing. This growth is due to the rising incidences of fungal infections. To make the most of the opportunities, market leaders are emphasizing more on the growth prospects in the fast-growing segments. Furthermore, the growing incidences of fungal infections are also offering huge growth opportunities to the market players. However, factors like the increase in multidrug-resistant fungal pathogens is creating restraints for the growth of the market participants. Therefore, to make the most of the opportunities, organizations are emphasizing more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Moreover, the constant research & development on vaccines and antibody-based immunotherapy offer a steady growth to the pharmaceutical sector. Many companies are also focusing on developing advanced antifungal therapeutics that offer relief from various antifungal infections. These factors are propelling the growth of the antifungal drugs market.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 16.28 Billion |
Market size value in 2031 | USD 22.78 Billion |
Growth Rate | 3.8% |
Base year | 2023 |
Forecast period | (2024-2031) |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Antifungal Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antifungal Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antifungal Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Antifungal Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2347
sales@skyquestt.com
USA +1 351-333-4748